Journal
ONCOTARGET
Volume 7, Issue 39, Pages 63611-63628Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.11553
Keywords
NumbL; Notch; cancer stem cells; tumor suppressor; tumorigenicity
Categories
Funding
- Spanish Ministry of Economy and Competitivity
- ISCIII - FEDER from Regional Development European Funds (European Union) [Fis: PI12/00137, PI15/00045]
- Consejeria de Ciencia e Innovacion [CTS-6844, CTS-1848]
- Consejeria de Salud of the Junta de Andalucia [PI-0306-2012, PI-0096-2014]
- ISCIII [PIE13/0004]
- FEDER funds
Ask authors/readers for more resources
NumbL, or Numb-like, is a close homologue of Numb, and is part of an evolutionary conserved protein family implicated in some important cellular processes. Numb is a protein involved in cell development, in cell adhesion and migration, in asymmetric cell division, and in targeting proteins for endocytosis and ubiquitination. NumbL exhibits some overlapping functions with Numb, but its role in tumorigenesis is not fully known. Here we showed that the downregulation of NumbL alone is sufficient to increase NICD nuclear translocation and induce Notch pathway activation. Furthermore, NumbL downregulation increases epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC)-related gene transcripts and CSC-like phenotypes, including an increase in the CSC-like pool. These data suggest that NumbL can act independently as a tumor suppressor gene. Furthermore, an absence of NumbL induces chemoresistance in tumor cells. An analysis of human tumors indicates that NumbL is downregulated in a variable percentage of human tumors, with lower levels of this gene correlated with worse prognosis in colon, breast and lung tumors. Therefore, NumbL can act as an independent tumor suppressor inhibiting the Notch pathway and regulating the cancer stem cell pool.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available